Immunogen (IMGN) Misses Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q1 EPS of ($0.30), $0.10 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $10.59 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
